Literature DB >> 2246614

Metabolic variables of cholesterol during squalene feeding in humans: comparison with cholestyramine treatment.

T E Strandberg1, R S Tilvis, T A Miettinen.   

Abstract

Squalene, a key intermediate of cholesterol synthesis, is present especially in olive oil. Regulation of cholesterol metabolism by dietary squalene in man is unknown, even though olive oil users in Mediterranean areas have low serum cholesterol levels. We have investigated absorption and serum levels of squalene and cholesterol and cholesterol synthesis with the sterol balance technique and serum levels of cholesterol precursors in humans during squalene feeding (900 mg/d for 7-30 days). The results were compared with those during cholestyramine treatment. Fecal analysis suggested that about 60% of dietary squalene was absorbed. Serum squalene levels were increased 17 times, but serum triglyceride and cholesterol contents were unchanged. The squalene feeding significantly (P less than 0.05) increased serum levels of free (1.7-2.3 times) and esterified (1.9-2.4 times) methyl sterol contents, while elevations of free and esterified delta 8-cholesterol and lathosterol levels were inconsistent. Cholestyramine treatment modestly augmented free methyl sterol levels (1.3-1.7 times), less consistently than those of esterified ones, while, in contrast to the squalene feeding, serum contents of free and esterified delta 8-cholesterol and lathosterol were dramatically increased (3.3-8 times). Neither of the treatments significantly affected serum plant sterol and cholestanol levels. The squalene feeding had no consistent effect on absorption efficiency of cholesterol, but significantly increased (paired t-test, P less than 0.05) the fecal excretions of cholesterol and its nonpolar derivatives coprostanol, epicoprostanol, and coprostanone (655 +/- 83 SE to 856 +/- 146 mg/d) and bile acids (212 +/- 24 to 255 +/- 24 mg/d), indicating an increase of cholesterol synthesis by about 50%. We suggest that a substantial amount of dietary squalene is absorbed and converted to cholesterol in humans, but this squalene-induced increase in synthesis is not associated with consistent increases of serum cholesterol levels. The clearly increased serum contents of esterified methyl sterols may reflect stimulated tissue acyl CoA: cholesterol acyltransferase (ACAT, EC 2.3.1.26) activity during squalene feeding as these sterols are not esterified in serum.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2246614

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  13 in total

1.  Radioprotection of mice by dietary squalene.

Authors:  H M Storm; S Y Oh; B F Kimler; S Norton
Journal:  Lipids       Date:  1993-06       Impact factor: 1.880

2.  Vascular effects and safety of supplementation with shark liver oil in middle-aged and elderly males.

Authors:  Naobumi Hamadate; Yoshiyuki Matsumoto; Kayoko Seto; Tetsuro Yamamoto; Hideyo Yamaguchi; Takashi Nakagawa; Etsushi Yamamoto; Mitsuhiko Fukagawa; Kazunaga Yazawa
Journal:  Exp Ther Med       Date:  2015-06-11       Impact factor: 2.447

3.  Amaranth oil increased fecal excretion of bile Acid but had no effect in reducing plasma cholesterol in hamsters.

Authors:  Luíla Ivini Andrade de Castro; Rosana Aparecida Manólio Soares; Paulo H N Saldiva; Roseli A Ferrari; Ana M R O Miguel; Claudia A S Almeida; José Alfredo Gomes Arêas
Journal:  Lipids       Date:  2013-03-02       Impact factor: 1.880

4.  The effect of consecutive steps of refining on squalene content of vegetable oils.

Authors:  Cevdet Nergiz; Deniz Celikkale
Journal:  J Food Sci Technol       Date:  2010-12-21       Impact factor: 2.701

5.  Steroidal compounds in commercial parenteral lipid emulsions.

Authors:  Zhidong Xu; Kevin A Harvey; Thomas Pavlina; Guy Dutot; Mary Hise; Gary P Zaloga; Rafat A Siddiqui
Journal:  Nutrients       Date:  2012-08-13       Impact factor: 5.717

6.  Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.

Authors:  Donato Cosco; Flavio Rocco; Maurizio Ceruti; Margherita Vono; Massimo Fresta; Donatella Paolino
Journal:  Int J Nanomedicine       Date:  2012-05-23

Review 7.  Methods for obtaining and determination of squalene from natural sources.

Authors:  Ovidiu Popa; Narcisa Elena Băbeanu; Ioana Popa; Sultana Niță; Cristina Elena Dinu-Pârvu
Journal:  Biomed Res Int       Date:  2015-01-28       Impact factor: 3.411

8.  Dietary squalene increases high density lipoprotein-cholesterol and paraoxonase 1 and decreases oxidative stress in mice.

Authors:  Clara Gabás-Rivera; Cristina Barranquero; Roberto Martínez-Beamonte; María A Navarro; Joaquín C Surra; Jesús Osada
Journal:  PLoS One       Date:  2014-08-12       Impact factor: 3.240

Review 9.  Critical Review on the Significance of Olive Phytochemicals in Plant Physiology and Human Health.

Authors:  Irene Gouvinhas; Nelson Machado; Carla Sobreira; Raúl Domínguez-Perles; Sónia Gomes; Eduardo Rosa; Ana I R N A Barros
Journal:  Molecules       Date:  2017-11-16       Impact factor: 4.411

10.  Pharmacokinetics, biodistribution and metabolism of squalenoyl adenosine nanoparticles in mice using dual radio-labeling and radio-HPLC analysis.

Authors:  Alice Gaudin; Sinda Lepetre-Mouelhi; Julie Mougin; Martine Parrod; Grégory Pieters; Sébastien Garcia-Argote; Olivier Loreau; Jordan Goncalves; Hélène Chacun; Yann Courbebaisse; Pascal Clayette; Didier Desmaële; Bernard Rousseau; Karine Andrieux; Patrick Couvreur
Journal:  J Control Release       Date:  2015-06-16       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.